contemporarypediatrics

Large data set shows infant sleep stabilizes within first year

Analysis of nearly 900 million hours of monitored infant sleep shows rapid stabilization of sleep patterns in the first year of life. Owlet, Inc. released its first annual Baby Sleep Report, analyzing ...
contemporarypediatrics

Themes identified for using GLP-1 RAs to manage obesity in food-insecure children

In a recent study, caregiver experiences, trust, and family values shaped decisions about GLP-1 medications for children with obesity. Lifestyle changes remain first-line for pediatric obesity, but ...
contemporarypediatrics

FDA clears portable incubator for thermoregulation in preterm infants

FDA grants 510(k) clearance to a portable neonatal incubator designed to support thermoregulation and keep preterm infants close to mothers. mOm Incubators Limited announced that the FDA has granted ...
contemporarypediatrics

INTEGUMENT-PED trial shows consistent efficacy of roflumilast cream in children aged 2 to 5

Vimal H. Prajapati, MD, discusses the latest roflumilast cream data from the INTEGUMENT-PED trial for pediatric atopic dermatitis. Managing atopic dermatitis (AD) in young children requires balancing ...
contemporarypediatrics

ACIP votes to update hepatitis B vaccine recommendation for infants

"For infants born to HBs-Ag-negative women: ACIP recommends individual-based decision-making, in consultation with a health care provider, for parents deciding when or if to give the HBV vaccine, ...
contemporarypediatrics

Prepandemic diet quality similar among WIC participants and income-eligible nonparticipants

A prepandemic NHANES analysis found no significant differences in fruit, vegetable, or overall diet quality between WIC participants and eligible nonparticipants. No significant prepandemic ...
contemporarypediatrics

FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy

FDA approves Itvisma for patients 2 years and older with SMA, making it the first FDA-approved gene replacement therapy for this population. FDA approved Itvisma as the first gene replacement therapy ...
contemporarypediatrics

Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care

For over 100 years, type 1 diabetes (T1D) has traditionally been diagnosed and treated at the onset of symptomatic hyperglycemia, often accompanied by severe disease, including life-threatening ...
contemporarypediatrics

GeneDx receives FDA Breakthrough Device Designation for whole genome and exome tests

FDA grants Breakthrough Device Designation to GeneDx genome and exome tests supporting diagnosis of life-threatening genetic disorders. The FDA has granted Breakthrough Device Designation to GeneDx’s ...
contemporarypediatrics

FDA approves first treatment for thymidine kinase 2 deficiency

FDA approves Kygevvi, the first therapy for thymidine kinase 2 deficiency, a rare mitochondrial disease marked by muscle weakness and early death. The US Food and Drug Administration (FDA) has ...
contemporarypediatrics

Baricitinib demonstrates sustained hair regrowth in adolescents with alopecia areata

New one-year data showed that baricitinib continued scalp, eyebrow, and eyelash regrowth in adolescents with severe alopecia areata. One-year data from BRAVE-AA-PEDS confirm baricitinib’s robust and ...
contemporarypediatrics

AAP, AHA update pediatric cardiopulmonary resuscitation, emergency cardiovascular care guidelines

Newborn guidance emphasizes preparation, team training, and extended delayed cord clamping. The guidelines include new and revised recommendations across pediatric basic and advanced life support and ...